Mark Schiebler1
1UW-Madison, United States
Synopsis
Keywords: Contrast mechanisms: Hyperpolarized MR (Gas), Body: Lung, Cross-organ: Inflammation
Electronic Vaping Associated Lung Injury (EVALI) and Electronic
Nicotine Delivery Systems (ENDS) deliver addictive biologically active particulates
(one micron in size) directly into the blood stream. This is accomplished by a
battery powered heated filament that vaporizes the addictive agent along with
one or more carrier substances. We are at the beginning stages of understanding
the biological effects of these new delivery devices and if they will decrease the
incidence of lung cancer in their users compared with cigarettes. Pilot data
suggests that ENDS users have a disruption in their ability to match
ventilation with perfusion at the arteriolar level.
Overvew
Electronic Vaping Associated Lung Injury (EVALI) and Electronic
Nicotine Delivery Systems (ENDS) deliver addictive biologically active particulates
(one micron in size) directly into the blood stream. This is accomplished by a
battery powered heated filament that vaporizes the addictive agent along with
one or more carrier substances. The temperature of the filament, the metal
composition of the filament, the agent being vaporized, the carrier
molecule(s), the frequency of use, the depth of inspiration, the host’s genetic
response to particulates, other infections (e.g., COVID-19), all may have a
role in determining the presentation of these patients to the clinic with a
history of shortness of breath. (1) Hyperpolarized 123Xenon MRI spectroscopy is a proxy for regional
lung function. Pilot data suggests that ENDS
users have a disruption in their ability to match ventilation with perfusion at
the arteriolar level. (2) Early results using Fourier decomposition analysis of the
ventilation and perfusion signal intensities over the cardiac and respiratory
cycles has also been used to study ENDS users. This non contrast method has also shown decreased ventilation
and increased perfusion. (3) We are at the
beginning stages of understanding the biological effects of these new delivery
devices and if they will decrease the incidence of lung cancer in their users
compared with cigarette smokers. This is a fertile area for future research as
so little is really known about the role of vaping pens in the future of lung
health.Acknowledgements
No acknowledgement found.References
1. Kligerman
S, Raptis C, Larsen B, et al. Radiologic, Pathologic, Clinical, and Physiologic
Findings of Electronic Cigarette or Vaping Product Use-associated Lung Injury
(EVALI): Evolving Knowledge and Remaining Questions. Radiology. Mar 2020;294(3):491-505. doi:10.1148/radiol.2020192585
2. He M, Qing K, Tustison NJ, et al. Characterizing Gas Exchange
Physiology in Healthy Young Electronic-Cigarette Users with Hyperpolarized
(129)Xe MRI: A Pilot Study. Int J Chron
Obstruct Pulmon Dis. 2021;16:3183-3187. doi:10.2147/COPD.S324388
3. Nyilas S, Bauman G, Korten I, et al.
MRI Shows Lung Perfusion Changes after Vaping and Smoking. Radiology. Jul 2022;304(1):195-204. doi:10.1148/radiol.211327